Literature DB >> 2109038

Purification of macrophage deactivating factor.

S Srimal1, C Nathan.   

Abstract

Macrophage deactivation factor (MDF) in P815 tumor cell-conditioned medium was assayed by its suppression of the ability of activated mouse peritoneal macrophages to release hydrogen peroxide. MDF displayed properties of a soluble protein(s) associated with both low (8-25,000) and high (greater than 450,000) Mr fractions. MDF was purified 6,140-fold by a seven-step procedure: extraction with acid-ethanol; precipitation with ether; and fractionation on gel filtration, anion-exchange, diphenyl reversed-phase and C4 reversed-phase HPLC columns, the last column twice. The final preparation contained two species: (a) a approximately 13,000 Mr band on reducing or nonreducing SDS-PAGE and on autoradiograms after radioiodination with chloramine T, and (b) a 66,000 Mr species ranging from approximately 5% to approximately 50% of the protein detectable by silver strain. The 66,000 Mr species was identified as albumin from its NH2-terminal amino acid sequence. However, no amino acid sequence could be obtained for the approximately 13,000 Mr species, either in fluid phase or after electroelution of the corresponding SDS-PAGE band. Thus, approximately 13,000 Mr MDF associates tightly with albumin through a variety of separation techniques, and may have a blocked NH2 terminus. Purified MDF afforded 50% inhibition of activated macrophage H2O2 releasing capacity at a concentration of 1-10 nM. Separation of MDF from most higher Mr moieties was associated with disproportionately small increases in specific activity, suggesting MDF might be partially inactivated by purification. As purified, MDF was approximately 1,000-fold less potent at deactivating macrophages than TGF-beta. Antibodies that neutralized the macrophage-deactivating effect of TGF-beta did not inhibit deactivation by MDF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2109038      PMCID: PMC2187851          DOI: 10.1084/jem.171.4.1347

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin.

Authors:  A L Haas; P Ahrens; P M Bright; H Ankel
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

Review 2.  Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effects on the oxidase.

Authors:  C F Nathan; S Tsunawaki
Journal:  Ciba Found Symp       Date:  1986

3.  Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses.

Authors:  R A Harrell; G J Cianciolo; T D Copeland; S Oroszlan; R Snyderman
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

4.  Effects of tumour cell culture supernatants on some biochemical activities of macrophages.

Authors:  M Nelson; M L Booth; D S Nelson
Journal:  Aust J Exp Biol Med Sci       Date:  1982-10

5.  Alpha 2-macroglobulin 'fast' forms inhibit superoxide production by activated macrophages.

Authors:  M Hoffman; S R Feldman; S V Pizzo
Journal:  Biochim Biophys Acta       Date:  1983-11-08

6.  Activation of mouse peritoneal macrophages by lipopolysaccharide alters the kinetic parameters of the superoxide-producing NADPH oxidase.

Authors:  M Sasada; M J Pabst; R B Johnston
Journal:  J Biol Chem       Date:  1983-08-25       Impact factor: 5.157

7.  Inhibition of recombinant interferon-gamma-induced Ia antigen expression by shed B16 F10 melanoma cell membrane vesicles.

Authors:  D D Poutsiaka; D D Taylor; E M Levy; P H Black
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

8.  Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.

Authors:  C A Nacy
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

9.  Macrophage deactivation. Altered kinetic properties of superoxide-producing enzyme after exposure to tumor cell-conditioned medium.

Authors:  S Tsunawaki; C F Nathan
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

10.  Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells.

Authors:  A Szuro-Sudol; C F Nathan
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

View more
  4 in total

1.  Suppression of the reactive oxygen intermediates production of human macrophages by colorectal adenocarcinoma cell lines.

Authors:  A Siegert; C Denkert; A Leclere; S Hauptmann
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  A journey in science: promise, purpose, privilege.

Authors:  Carl Nathan
Journal:  Mol Med       Date:  2013-10-03       Impact factor: 6.354

3.  Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis.

Authors:  H W Pfister; K Frei; B Ottnad; U Koedel; A Tomasz; A Fontana
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

4.  Macrophage deactivation by interleukin 10.

Authors:  C Bogdan; Y Vodovotz; C Nathan
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.